-
FundamentalsTechnical LearningProtocol LearningQuality Share
-
Literature ReviewResearch FrontiersIndustry News
-
Technical Explanation
-
CRISPR-Editx Cancer cell model
-
Company OverviewTechnical Flyers
Research Frontiers
Research Frontiers
PODN and PODNL1: Emerging Target Genes with Potential Value in Disease Research
📅 20 August.2026
Read More →
CD33 Gene Editing Enters Clinical Testing in AML | A New CRISPR-Enabled Targeted Therapy Strategy
📅 18 August.2026
Read More →
Beyond Natural Targeting Limits: Engineered Serine Integrases Advance Large DNA Knock-in
📅 21 July.2026
Read More →
Cas12a2 CRISPR Breakthrough: RNA-Triggered Chromatin Shredding for Precision Cancer Cell Killing
📅 30 June.2026
Read More →
David Liu’s Team Reports Three Recent Prime Editing Breakthroughs: PERT, PE-PRISM, and LNP Delivery Advance Clinical Translation
📅 24 June.2026
Read More →
Nature Breakthrough: Prime Assembly Enables Precise 11 kb Large DNA Insertions
📅 2 June.2026
Read More →
OptiPrime for Prime Editing: How David R. Liu's AI Model Improves pegRNA Design and Gene Therapy Efficiency
📅 6 March.2026
Read More →
CRISPR screening in human neurons reveals new insights into Alzheimer’s disease.
📅 12 February.2026
Read More →
From Double Helix to Outpatient Cures: How Nobel Prizes Ignited the Gene Therapy Revolution
📅 19 January.2026
Read More →
At Just One Year Old, He Joins Nature's 10: The Story of a CRISPR Breakthrough
📅 22 December.2025
Read More →
[Literature Review] Decoding the Latest Nature Paper from David Liu’s Team: How Gene Editing Teaches Cells to “Ignore Errors”
📅 24 November.2025
Read More →
[Research highlight] Novel studies of CRISPR screening
📅 26 October.2024
Read More →
[Research frontier] CRISPR Detection Trends
📅 26 October.2024
Read More →
[Research Frontier] CRISPR screen decodes stimulatory responses of primary T cells
📅 26 October.2024
Read More →
[Research Frontier] New trends in CRISPR-- KO Cells Reveal Key Factors in Ferroptosis
📅 26 October.2024
Read More →
Subscribe
Please complete this required field.
Please complete this required field.
Please complete this required field.
You can unsubscribe from these communications at any time. For more information on how to unsubscribe, our privacy practices, and how we are committed to protecting and respecting your privacy, please review our Privacy Policy.
By clicking submit below, you consent to allow EDITGENE to store and process the personal information submitted above to provide you the content requested.